Who is this course for?
Primarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Online prescriber education for regulated clinicians covering screening, clinical considerations, prescribing fundamentals, medication interactions, contraindications, risk management, treatment-team coordination, and Canadian access pathways.
Psychedelic Prescriber Training is a clinically focused masterclass for physicians and nurse practitioners working in regulated medical settings. It is designed to build practical understanding of prescribing pathways, risk mitigation, and the Canadian regulatory context for psychedelic-assisted psychotherapy. The curriculum covers neurobiology and neuropharmacology, dosing, evidence appraisal, drug interactions, contraindications, adverse events, patient populations, and special medical considerations. It also addresses TheraPsil roles, assessment and referral, SAP pathways, Section 56 considerations, documentation, and collaboration with care teams. The format is fully online and combines pre-readings, training videos, a live seminar, a live Q&A, and a short quiz. The listed time commitment is 8 hours total, and there are separate psilocybin and MDMA versions with different clinical examples and case framing.
Primarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Intended for regulated clinicians; no additional prerequisites stated.
TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.
View all TheraPsil coursesPrimarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Intended for regulated clinicians; no additional prerequisites stated.
Format: Hybrid. Time commitment: 8 hours total.
The listed price is $750. Confirm the latest tuition, fees, and payment options on the provider website.
Listed CE/CME credits: 8. Confirm credential eligibility directly with the provider before enrolling.
This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.
The current listing status is Active. Use the provider website for the latest enrollment status.
By IPI
Shares course skills and categories
The IPI Online Psychedelic-Assisted Therapy Training is a year-long program designed for therapists, physicians, nurses, and other allied mental healthcare professionals who want to expand their skill set in psychedelic-assisted therapy.
Source lists: 140 hours
Delivery: Online
By CIIS
Shares course skills and categories
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.
Dates not announced
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research housed in the CIIS Center for Psychedelic Therapies and Research. The program offers hybrid or online training covering clinical competencies, research, ethics, and culturally informed approaches.
Dates not announced